Event Report 2020
-
Patient Organization Collaboration Promotion Committee
The 38th Pharmaceutical Association of Japan Patient Group Seminar held
Online-based patient group activities - What we can do now -
ICH Project
GCP Renovation Seminar" held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2020" was held.
-
International Committee
The 2nd Japan-Vietnam Joint Symposium was held.
-
Drug Evaluation Committee
The Joint Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee 2020 was held.
-
International Committee
The 8th Taiwan-Japan Pharmaceutical Exchange Conference held.
-
Biopharmaceutical Committee
Report on the BioJapan 2020
About the Biopharmaceutical Committee Seminar -
Code Compliance Promotion Committee
FY2020 Meeting of Code Administration Managers and Practitioners" held
-
Regulatory Affairs Committee
The 10th Annual Meeting of the Regulatory Science Society of Japan held
-
Quality Committee
Held the 47th GMP Case Study Workshop in FY2020
-
Public Relations Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Lessons learned from the spread of the new coronavirus and preparations for drug resistance (AMR) -
Public Relations Committee
Chairman's Press Conference" held
The Pharmaceutical Manufacturers Association of Japan (PMAJ) Activity Policy for FY2020, PMAJ Proposals for the Creation of Infectious Drugs and Vaccines, Proposals for the Framework Policy 2020, and Progress of the PMAJ Policy Recommendations 2019 -
International Committee
The 7th Nikkei-FT Conference on Infectious Diseases" held as a Pharmaceutical Association of Japan lunch session.
Recommendations to strengthen future infectious disease control through industry-academia-government collaboration -
ICH Project
ICH M8 eCTD v4.0 Revision Notice Briefing Session
Briefing Session on eCTD v4.0 Implementation in Japan -
ICH Project
ICH Vancouver Conference" held in web conference format
-
Quality Committee
The 22nd Pharmaceutical Quality Forum Symposium" was held
Current Status of ICH-Q Series -
Regulatory Affairs Committee
The 8th Symposium of the Pharmaceutical Affairs Committee held
Considering what can be done to make the face-to-face advice and review more efficient -
Intellectual Property Committee
2020 Life Science Intellectual Property Forum" held.
How to protect new businesses that use digital data as a source of value -
Pharmaceutical Counseling and Response Review Committee
The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
Considering how information should be provided to patients - Focusing on the next generation -
Pharmaceutical Counseling and Response Review Committee
The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
Considering how information should be provided to patients - Focusing on the next generation -
International Committee
The 4th Symposium on Japan-India Medical Products Regulations" was held
Mature discussion on drug regulation between Japan and India (Japan-India) and further development into an international cooperation scheme -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Trends in the revision of the Personal Information Protection Law and the legislative policy for medical information -
Public Relations Committee
Special program by the Pharmaceutical Manufacturers Association of Japan "Yamaguchi! Buchi Genki! ～KRY Yamaguchi Broadcasting Corporation "Yamaguchi!
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Pharmaceutical Manufacturers Association of Japan: Progress and Future - Pursuing Innovation and Solving Social Issues